TLSI TriSalus Life Sciences Inc
Price (delayed)
$5.53
Market cap
$168.63M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.98
Enterprise value
$180.79M
Highlights
TLSI's EPS has soared by 98% YoY
The gross profit has soared by 78% YoY and by 8% QoQ
TriSalus Life Sciences's quick ratio has decreased by 38% YoY and by 8% from the previous quarter
TriSalus Life Sciences's net income has decreased by 20% YoY
Key stats
What are the main financial stats of TLSI
Market
Valuations
Earnings
Shares outstanding
30.49M
Market cap
$168.63M
Enterprise value
$180.79M
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
5.45
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
6.72
Revenue
$26.89M
Gross profit
$23.42M
Operating income
-$43.04M
Net income
-$55.46M
EBIT
-$53.43M
EBITDA
-$52.44M
Free cash flow
-$44.98M
Per share
Balance sheet
Liquidity
EPS
-$1.98
EPS diluted
-$1.98
Free cash flow per share
-$1.7
Book value per share
-$0.7
Revenue per share
$1.01
TBVPS
$1.04
Total assets
$27.48M
Total liabilities
$47.91M
Debt
$23.45M
Equity
-$20.43M
Working capital
$13.89M
Debt to equity
-1.15
Current ratio
2.4
Quick ratio
1.63
Net debt/EBITDA
-0.23
Margins
Efficiency
Dividend
EBITDA margin
-195%
Gross margin
87.1%
Net margin
-206.2%
Operating margin
-160%
Return on assets
-216.6%
Return on equity
N/A
Return on invested capital
-388.2%
Return on capital employed
-304.3%
Return on sales
-198.7%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
TLSI stock price
How has the TriSalus Life Sciences stock price performed over time
Intraday
0.55%
1 week
-0.9%
1 month
-3.99%
1 year
-43.57%
YTD
10.38%
QTD
0.18%
Financial performance
How have TriSalus Life Sciences's revenue and profit performed over time
Revenue
$26.89M
Gross profit
$23.42M
Operating income
-$43.04M
Net income
-$55.46M
Gross margin
87.1%
Net margin
-206.2%
The gross profit has soared by 78% YoY and by 8% QoQ
The revenue has surged by 68% year-on-year and by 9% since the previous quarter
TLSI's operating margin has soared by 51% YoY and by 25% QoQ
TLSI's net margin is up by 29% year-on-year and by 6% since the previous quarter
Growth
What is TriSalus Life Sciences's growth rate over time
Valuation
What is TriSalus Life Sciences stock price valuation
P/E
N/A
P/B
N/A
P/S
5.45
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
6.72
TLSI's EPS has soared by 98% YoY
TriSalus Life Sciences's equity has increased by 15% from the previous quarter
The revenue has surged by 68% year-on-year and by 9% since the previous quarter
TLSI's P/S is 11% below its last 4 quarters average of 6.1
Efficiency
How efficient is TriSalus Life Sciences business performance
The return on invested capital is up by 48% since the previous quarter
TLSI's ROS is up by 31% YoY and by 8% QoQ
TriSalus Life Sciences's ROA has decreased by 8% YoY and by 8% from the previous quarter
Dividends
What is TLSI's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for TLSI.
Financial health
How did TriSalus Life Sciences financials performed over time
The company's total assets is 43% lower than its total liabilities
TLSI's total liabilities has soared by 91% YoY but it is down by 15% QoQ
TriSalus Life Sciences's quick ratio has decreased by 38% YoY and by 8% from the previous quarter
TriSalus Life Sciences's debt to equity has decreased by 22% from the previous quarter
TriSalus Life Sciences's equity has increased by 15% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.